Publications: Dr Hamish Miller
Colosimo S, Miller H, Koutoukidis DA, Marjot T, Tan GD, Harman DJ, Aithal GP, Manousou P et al.
(
2024
)
.
Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD
.
Diabetes Research and Clinical Practice
vol.
217
,
Miller H, Garrido P, Li W, Kumar R, Gines I, Nikolaou N, Potter T, Bailey M et al.
(
2024
)
.
THU-236-YI Oxysterol treatment causes indirect stellate cell activation: a potential mechanism linking steroid metabolising enzyme dysregulation with fibrosis
.
Journal of Hepatology
vol.
80
,
Miller H, Harman D, Aithal GP, Manousou P, Cobbold JF, Parker R, Sheridan D, Newsome PN et al.
(
2024
)
.
Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): study protocol for a multicentre, prospective validation study
.
BMJ Open
vol.
14
,
(
1
)
Colosimo S, Miller H, Koutoukidis D, Marjot T, Tan G, Harman D, Aithal G, Manousou P et al.
(
2023
)
.
The role of glycated haemoglobin in predicting disease severity in non-alcoholic fatty liver disease
.
Endocrine Abstracts
Li W, Sheridan D, McPherson S, Alazawi W, Abeysekera K, Marjot T, Brennan P, Mahgoub S et al.
(
2023
)
.
National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022
.
JHEP Reports
vol.
5
,
(
12
)
Mir IG, Kumar R, Garrido P, Li W, Miller H, Saihi H, Hood G, Alazawi W
(
2023
)
.
FRI-520 B-cell activating factor in non-alcoholic steatohepatitis
.
Journal of Hepatology
vol.
78
,
Miller H, Colosimo S, Li W, Cobbold J, Alazawi W, Harman D, Aithal G, Manousou P et al.
(
2023
)
.
SAT-483 Developing a risk stratification tool for advanced NAFLD fibrosis using routinely measured clinical variables in a diabetes clinic annual review
.
Journal of Hepatology
vol.
78
,